hemotune offers a versatile platform for targeted magnetic separation By merging nanotechnology with advanced engineering, hemotune has created a versatile platform for highly selective, efficient, and scalable magnetic separation. In medicine, this means removing disease triggers and harmful agents directly from the bloodstream instead of adding compounds, aiming to reduce side effects and enable multi-target strategies. Tunable for applications in healthcare and high-value processes, the platform delivers precision and flexibility across the entire value chain.
| Website | http://www.hemotune.com |
| Employees | 29 (20 on RocketReach) |
| Founded | 2017 |
| Address | Wagistrasse 27, Schlieren, Zurich 8952, CH |
| Phone | +41 44 633 41 51 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+12 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Biotechnology, Science and Engineering, Health Care, Life Science, Therapeutics |
| Keywords | Innovative Medical Devices, Medical Technology, Medical Innovation, Emergency Medicine, Healthcare Technology, Patient Care, Health Tech Startup, Medical Equipment, Critical Care, Therapeutic Solutions, Therapeutic Devices, Breakthrough Technology, Health Solutions, Biomedical Engineering, Precision Medicine, Digital Health, Surgical Devices |
Looking for a particular hemotune AG employee's phone or email?
Lukas Langenegger is the CEO and co-founder of hemotune AG.
20 people are employed at hemotune AG.
hemotune AG is based in Schlieren, Zurich.